CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 90 entries

View as:

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

Phase: N/A Priority: Normal

NCT ID: NCT02368665 Org: User:

Start: 12/31/14 End: 11/30/16 Due: 11/30/17

PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT06332638 Org: User:

Start: 03/19/24 End: 07/31/24 Due: 07/31/25

Bioequivalence Study of CJ-30059

Phase: N/A Priority: Normal

NCT ID: NCT02173912 Org: User:

Start: 06/30/14 End: 08/31/14 Due: 08/31/15

Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT03542916 Org: User:

Start: 10/31/14 End: 12/31/15 Due: 12/31/16

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis

Phase: N/A Priority: Normal

NCT ID: NCT04022096 Org: User:

Start: 06/18/19 End: 06/23/21 Due: 06/23/22

A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients

Phase: N/A Priority: Normal

NCT ID: NCT03317223 Org: User:

Start: 10/17/17 End: 01/24/19 Due: 01/24/20

Food-Effect on PK and PD of Single Oral Dose of Tegoprazan in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT03863938 Org: User:

Start: 03/27/19 End: 06/25/19 Due: 06/25/20

A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01925313 Org: User:

Start: 12/31/12 End: 05/31/13 Due: 05/31/14

Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT04171687 Org: User:

Start: 10/21/19 End: 04/09/20 Due: 04/09/21

A Study to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT04485884 Org: User:

Start: 08/13/20 End: 06/30/21 Due: 06/30/22

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Phase: N/A Priority: Normal

NCT ID: NCT01765452 Org: User:

Start: 10/31/12 End: 08/31/13 Due: 08/31/14

Safety and Immunogenicity of High-dose IN-B001 in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT04637919 Org: User:

Start: 12/31/20 End: 12/31/21 Due: 12/31/22

Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs

Phase: N/A Priority: Normal

NCT ID: NCT04840550 Org: User:

Start: 05/07/21 End: 07/31/24 Due: 07/31/25

Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients

Phase: N/A Priority: Normal

NCT ID: NCT05933031 Org: User:

Start: 02/27/23 End: 12/31/24 Due: 12/31/25

Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT04654078 Org: User:

Start: 01/18/21 End: 02/15/21 Due: 02/15/22

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

Phase: N/A Priority: Normal

NCT ID: NCT02368652 Org: User:

Start: 12/31/14 End: 11/30/15 Due: 11/30/16

A Drug Interaction Study of SLM0807 and HKB0701 in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01039896 Org: User:

Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT04221321 Org: User:

Start: 01/07/20 End: 04/20/20 Due: 04/20/21

Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01489774 Org: User:

Start: 05/31/11 End: 06/30/12 Due: 06/30/13

Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01765023 Org: User:

Start: 10/31/12 End: 01/31/13 Due: 01/31/14

Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT03657472 Org: User:

Start: 09/19/16 End: 11/09/16 Due: 11/09/17

Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT02146625 Org: User:

Start: 11/30/14 End: 09/30/15 Due: 09/30/16

Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

Phase: N/A Priority: Normal

NCT ID: NCT01735890 Org: User:

Start: 09/30/12 End: 11/30/12 Due: 11/30/13

Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT04297865 Org: User:

Start: 02/24/20 End: 02/28/21 Due: 02/28/22

Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

Phase: N/A Priority: Normal

NCT ID: NCT03536598 Org: User:

Start: 10/14/16 End: 09/04/17 Due: 09/04/18

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy	NCT02368665	HK inno.N Corporation	user2@example.com	None	2014-12-31	2016-11-30	2017-11-30	-	-	2025-07-14
PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects	NCT06332638	HK inno.N Corporation	user2@example.com	None	2024-03-19	2024-07-31	2025-07-31	-	-	2025-07-14
Bioequivalence Study of CJ-30059	NCT02173912	HK inno.N Corporation	user2@example.com	None	2014-06-30	2014-08-31	2015-08-31	-	-	2025-07-14
Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers	NCT03542916	HK inno.N Corporation	user2@example.com	None	2014-10-31	2015-12-31	2016-12-31	-	-	2025-07-14
Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis	NCT04022096	HK inno.N Corporation	user2@example.com	None	2019-06-18	2021-06-23	2022-06-23	-	-	2025-07-14
A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients	NCT03317223	HK inno.N Corporation	user2@example.com	None	2017-10-17	2019-01-24	2020-01-24	-	-	2025-07-14
Food-Effect on PK and PD of Single Oral Dose of Tegoprazan in Healthy Male Subjects	NCT03863938	HK inno.N Corporation	user2@example.com	None	2019-03-27	2019-06-25	2020-06-25	-	-	2025-07-14
A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers	NCT01925313	HK inno.N Corporation	user2@example.com	None	2012-12-31	2013-05-31	2014-05-31	-	-	2025-07-14
Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers	NCT04171687	HK inno.N Corporation	user2@example.com	None	2019-10-21	2020-04-09	2021-04-09	-	-	2025-07-14
A Study to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male Subjects	NCT04485884	HK inno.N Corporation	user2@example.com	None	2020-08-13	2021-06-30	2022-06-30	-	-	2025-07-14
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone	NCT01765452	HK inno.N Corporation	user2@example.com	None	2012-10-31	2013-08-31	2014-08-31	-	-	2025-07-14
Safety and Immunogenicity of High-dose IN-B001 in Healthy Subjects	NCT04637919	HK inno.N Corporation	user2@example.com	None	2020-12-31	2021-12-31	2022-12-31	-	-	2025-07-14
Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs	NCT04840550	HK inno.N Corporation	user2@example.com	None	2021-05-07	2024-07-31	2025-07-31	-	-	2025-07-14
Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients	NCT05933031	HK inno.N Corporation	user2@example.com	None	2023-02-27	2024-12-31	2025-12-31	-	-	2025-07-14
Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers	NCT04654078	HK inno.N Corporation	user2@example.com	None	2021-01-18	2021-02-15	2022-02-15	-	-	2025-07-14
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy	NCT02368652	HK inno.N Corporation	user2@example.com	None	2014-12-31	2015-11-30	2016-11-30	-	-	2025-07-14
A Drug Interaction Study of SLM0807 and HKB0701 in Healthy Subjects	NCT01039896	HK inno.N Corporation	user2@example.com	None	2009-06-30	2009-08-31	2010-08-31	-	-	2025-07-14
Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers	NCT04221321	HK inno.N Corporation	user2@example.com	None	2020-01-07	2020-04-20	2021-04-20	-	-	2025-07-14
Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects	NCT01489774	HK inno.N Corporation	user2@example.com	None	2011-05-31	2012-06-30	2013-06-30	-	-	2025-07-14
Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects	NCT01765023	HK inno.N Corporation	user2@example.com	None	2012-10-31	2013-01-31	2014-01-31	-	-	2025-07-14
Bioequivalence Study of CJ-30061 in Healthy Male Volunteers	NCT03657472	HK inno.N Corporation	user2@example.com	None	2016-09-19	2016-11-09	2017-11-09	-	-	2025-07-14
Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects	NCT02146625	HK inno.N Corporation	user2@example.com	None	2014-11-30	2015-09-30	2016-09-30	-	-	2025-07-14
Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet	NCT01735890	HK inno.N Corporation	user2@example.com	None	2012-09-30	2012-11-30	2013-11-30	-	-	2025-07-14
Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects	NCT04297865	HK inno.N Corporation	user2@example.com	None	2020-02-24	2021-02-28	2022-02-28	-	-	2025-07-14
Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia	NCT03536598	HK inno.N Corporation	user2@example.com	None	2016-10-14	2017-09-04	2018-09-04	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance